All Stories

  1. Protective Action of 3,5-Diiodo-L-Thyronine on Cigarette Smoke-Induced Mitochondrial Dysfunction in Human Alveolar Epithelial Cells
  2. miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis
  3. Cigarette Smoke Exposure and microRNA in Human Alveolar Macrophages: A Pilot Study
  4. MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study
  5. MicroRNAs Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study
  6. Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
  7. A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome
  8. Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk
  9. Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study
  10. The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?
  11. Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience
  12. Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
  13. Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antiinflammtory agents with in vivo efficacy
  14. Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
  15. Formulation of Solid Lipid Nanoparticles Loaded with Nociceptin/Orphanin FQ (N/OFQ) and Characterization in a Murine Model of Airway Hyperresponsiveness
  16. Circulating MicroRNAs Expression Profile in Lung Inflammation: A Preliminary Study
  17. Similar Programmed Death Ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
  18. Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease
  19. Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications
  20. Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury
  21. SNPs in asthma patients: gender difference in anti-leukotriene therapy
  22. 5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse
  23. Formulation and Characterization of Solid Lipid Nanoparticles Loading RF22-c, a Potent and Selective 5-LO Inhibitor, in a Monocrotaline-Induced Model of Pulmonary Hypertension
  24. Functional contribution of sphingosine‐1‐phosphate to airway pathology in cigarette smoke‐exposed mice
  25. Montelukast induces better control of symptoms and management of lung function, and decreased inflammation in women compared with men
  26. Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men
  27. Panitumumab Induced Forearm Panniculitis in Two Women With Metastatic Colon Cancer
  28. Leukotriene-mediated sex dimorphism in murine asthma-like features during allergen sensitization
  29. N/OFQ-NOP System and Airways
  30. Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness
  31. Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study
  32. StAR protein and steroidogenic enzyme expressions in the rat Harderian gland
  33. Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema
  34. Toll-Like Receptor 4 Is Essential for the Expression of Sphingosine-1-Phosphate-Dependent Asthma-Like Disease in Mice
  35. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma
  36. theophylline affect human bronchial epithelial cells
  37. Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate
  38. Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness
  39. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model
  40. The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo
  41. Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
  42. Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation
  43. New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness
  44. Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation
  45. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes
  46. Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS
  47. Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide
  48. Effects of sex hormones on bronchial reactivity during the menstrual cycle
  49. The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs
  50. Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice
  51. Skeletal Muscle Oxidative Metabolism in an Animal Model of Pulmonary Emphysema
  52. Plasma glutamine decreases immediately after surgery and is related to incisiveness